Intuitive Surgical (NASDAQ:ISRG) had its price objective hosited by SunTrust from $480.00 to $635.00 in a report released on Thursday, AmericanBankingNews.com reports. Intuitive Surgical, Inc. (NASDAQ:ISRG) shares after opening at $535.00 moved to $536.67 on last trade day and at the end of the day closed at $505.52. Company price to sales ratio in past twelve months was calculated as 8.56 and price to cash ratio as 13.81. Intuitive Surgical, Inc. (NASDAQ:ISRG) showed a positive weekly performance of 16.21%.
Alexion Pharmaceuticals (NASDAQ:ALXN) has earned a consensus rating of “Buy” from the nineteen brokerages that are presently covering the stock, StockRatingsNetwork.com reports. Four research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $181.88. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares fell -5.92% in last trading session and ended the day on $142.50. ALXN return on equity ratio is recorded as 11.20% and its return on assets is 8.50%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) yearly performance is 43.65%.
Biogen Idec Inc. (NASDAQ:BIIB) CEO said Thursday the state’s drug makers are producing breakthrough treatments for conditions like multiple sclerosis. But he said innovation is threatened by federal funding cuts for research and payments that don’t allow companies to recover their investments. Biogen Idec Inc. (NASDAQ:BIIB) shares moved down -4.50% in last trading session and was closed at $288.27, while trading in range of $286.30 – $305.48. Biogen Idec Inc. (NASDAQ:BIIB) year to date (YTD) performance is 3.11%.
Akamai Technologies, Inc. (NASDAQ:AKAM), the leading provider of cloud services for delivering, optimizing and securing online content and business applications, announced that the company will hold a conference call for investors on Thursday, May 1, 2014 at 4:30 p.m. ET. Akamai Technologies, Inc. (NASDAQ:AKAM) weekly performance is -6.68%. On last trading day company shares ended up $54.35. Akamai Technologies, Inc. (NASDAQ:AKAM) distance from 50-day simple moving average (SMA50) is -5.51%. Analysts mean target price for the company is $63.47.